{
  "trial_id": "NCT00346801",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "histological or cytological evidence of NSCLC",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Nonresectable Stage II or III NSCLC",
      "label": "unknown",
      "evidence": "The tumor is located in the T-L spine, unresectable anaplastic astrocytoma s/p radiation."
    },
    {
      "criterion": "KPS is greater than or equal to 70",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Age is greater than or equal to 18 or less than or equal to 80",
      "label": "met",
      "evidence": "Patient is a 45-year-old man."
    },
    {
      "criterion": "ANC count (segs & bands) is greater than or equal to 2000/mm3 and platelet count is greater than or equal to 100,000/mm3",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Serum creatinine less than or equal to 1.5 mg/dL",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Total bilirubin is less than or equal to 1.5 times the institutional upper limits of normal value, SGOT less than or equal to 1.5 times the the institutional upper limit of normal.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients may not be entered on investigational therapeutic trials",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Patient may have prior chemotherapy. Chemotherapy must have been completed 4 weeks prior to study entry.",
      "label": "unknown",
      "evidence": "The patient initially presented with RLE weakness where his right knee gave out with difficulty walking and right anterior thigh numbness."
    },
    {
      "criterion": "Patients taking cardio-protective dose of aspirin 81 mg are allowed.",
      "label": "met",
      "evidence": "Patient is on high-dose steroids, hypertension, and chronic pain treatment."
    }
  ],
  "exclusion": [
    {
      "criterion": "History of poorly controlled hypertension (systolic >150 mm Hg), angina, or other cardiac abnormalities or history of MI or CHF in the last 6 months.",
      "label": "triggers",
      "evidence": "Patient has high-dose steroids and hypertension."
    },
    {
      "criterion": "General medical or psychological conditions which would not permit the patient to complete the study or sign the informed consent.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pregnancy or women of child bearing potential who do not use an effective (for them) method of birth control throughout their participation in this study.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who are currently receiving or have received amifostine for radioprotection within the prior six months are excluded.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patient with history of malignancy other than skin cancer or Carcinoma in-situ within 2 years.",
      "label": "triggers",
      "evidence": "The patient has anaplastic astrocytoma of the spine."
    },
    {
      "criterion": "Patients who are allergic to Sulfonamides, NSAIDS or Celebrex will be excluded from this protocol.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients who use routine NSAIDS such as high dose daily use of Aspirin higher than 2 Gm per day will be excluded. Patients will be allowed to take low dose aspirin (less than 200 mg per day).",
      "label": "triggers",
      "evidence": "Patient is on high-dose steroids and hypertension treatment."
    },
    {
      "criterion": "History of cardiovascular diseases that might include one of the following: myocardial infarction, angina, coronary angioplasty, congestive heart failure, stroke, or coronary bypass surgery in the last 6 months.",
      "label": "triggers",
      "evidence": "Patient has high-dose steroids and hypertension."
    }
  ],
  "notes": "The patient's history of anaplastic astrocytoma and current treatment with high-dose steroids and hypertension raises concerns about eligibility. Further evaluation is needed to determine the patient's overall health status and ability to participate in the study.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00346801",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b"
  }
}